Availability of Internationally Controlled Drugs

Ensuring Adequate Access for Medical and Scientific Purposes

image of Availability of Internationally Controlled Drugs
This supplement to the INCB’s Annual Report 2015 analyses global access to narcotic drugs and psychotropic substances. The report provides an introduction to the drug control conventions, human rights, action taken by the Board, and the report’s methodology. It focuses on narcotic drugs, examining supply and demand of opiate raw materials and opioids, availability of opioid analgesics, and impediments to their access for medical and scientific purposes, while analysing the situation of psychotropic substances, considering their use as analgesics, anti-epileptics, anxiolytics, sedative-hypnotics and stimulants. It also covers the topic of availability of internationally controlled drugs for the treatment of opioid dependence, and looks into simplified provision in emergency situations.

English French, Spanish, Chinese


Executive summary / Acknowledgements

Indispensable and adequately available for medical and scientific purposes: those two fundamental principles were set forth in the Single Convention on Narcotic Drugs of 1961 as amended by the 1972 Protocol. Later, psychotropic substances were also recognized as being indispensable for medical and scientific purposes. In the Convention on Psychotropic Substances of 1971, Parties further recognized that the availability of such substances should not be unduly restricted.

English French, Spanish, Chinese

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error